Insmed Inc (NASDAQ:INSM)
| 26.74 BATS BZX Real-Time Price As of 3:13pm ET |  -0.45 / -1.66%Today’s Change | 12.09 Today|||52-Week Range 34.94 | +11.98% Year-to-Date |
Latest INSM News | Press Releases
| European advisory group backs Insmed's Arikayce Jul 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 27.19 |
| Today’s open | 26.87 |
| Day’s range | 26.52 - 27.18 |
| Volume | 11,752 |
| Average volume (3 months) | 1,069,943 |
| Market cap | $2.6B |
Data as of 3:07pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | +28.68% |
| Earnings growth (this year) | +9.22% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +1,287.56% |
| P/E ratio | NM |
| Price/Sales | 14.80 |
| Price/Book | 8.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TPTXTurning Point Therap... | -3.00 | -4.89% |
| PRNBPrincipia Biopharma ... | -3.24 | -3.65% |
| ALKSAlkermes Plc | -0.10 | -0.53% |
| TAROTaro Pharmaceutical ... | -0.26 | -0.40% |
Data as of 3:12pm ET, 08/04/2020
Financials
| Next reporting date | August 6, 2020 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $136.5M |
| Annual profit (last year) | -$254.3M |
| Net profit margin | -186.37% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
